Acerand Therapeutics
PrivateCompany Overview
Acerand Therapeutics operates in Healthcare & Life Sciences and is based in Indianapolis, Indiana. It was founded in 2020.
Acerand Therapeutics is a biotechnology company that focuses on the discovery and development of novel small-molecule drug candidates for the treatment of oncology, immunology, and metabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Acerand Therapeutics Comparables
Compare Acerand Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Synnovation Therapeutics | 88% | |
| SciBrunch Therapeutics | 83% | |
| Duke Street Bio | 81% |
For institutional investors. Book with your work email.
Acerand Therapeutics Funding Rounds
Historical fundraising activity
Acerand Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lilly Asia Ventures | Seed |
Acerand Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Acerand Therapeutics's valuation, stock price, and market status.
Is Acerand Therapeutics a public or private company?
Acerand Therapeutics is a private company.
What is the current stock price of Acerand Therapeutics?
Acerand Therapeutics is a private company, so its shares have no public market price. Caplight tracks Acerand Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Acerand Therapeutics worth (valuation)?
Valuation information for Acerand Therapeutics is not publicly available.
Can I buy Acerand Therapeutics stock?
Acerand Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Acerand Therapeutics's last funding round?
Funding round information for Acerand Therapeutics is not publicly available.
Who are the main investors in Acerand Therapeutics?
Key investors in Acerand Therapeutics include Lilly Asia Ventures.
Will Acerand Therapeutics IPO soon?
No public IPO plans have been announced for Acerand Therapeutics.
How can I track Acerand Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Acerand Therapeutics's shares on secondary markets.